Incretin hormone agonists: Current and emerging pharmacotherapy for obesity management - Alhomoud - 2024 - Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy US$ 29.14 Min. order: 1 piece ★★★★★ 4.8 (297 reviews) Sold : Login>>
Novo's Phase 3 CagriSema results disappoint analysts, sending stock tumbling - MM+M US$ 28.76 Min. order: 1 piece ★★★★★ 4.8 (173 reviews) Sold : Login>>
PDF] Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial US$ 21.80 Min. order: 1 piece ★★★★★ 4.1 (51 reviews) Sold : Login>>